Brief: Usana Health Sciences Finishes Strong 2020 With 14.5% Fourth Quarter Net Sales Growth And 32.6% Diluted EPS Growth

USANA Health Sciences

09/02/2021 22:07

Feb 9 (Reuters) - USANA Health Sciences Inc  USNA.N :
    * USANA HEALTH SCIENCES FINISHES STRONG 2020 WITH 14.5%
FOURTH
QUARTER NET SALES GROWTH AND 32.6% DILUTED EPS GROWTH
    * Q4 EARNINGS PER SHARE $1.87
    * Q4 SALES $310.5 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$291.5
MILLION
    * Q4 EARNINGS PER SHARE ESTIMATE $1.43 -- REFINITIV IBES
DATA
    * PROVIDES INITIAL 2021 NET SALES GUIDANCE OF $1.21 TO $1.27
BILLION AND INITIAL DILUTED EPS GUIDANCE OF $6.00 TO $6.45
    * BOARD OF DIRECTORS AUTHORIZES UP TO $150 MILLION IN SHARE
REPURCHASE AUTHORIZATION

Source text for Eikon:  ID:nBw8SFsjca 
Further company coverage:  USNA.N 

 ((Reuters.Briefs@thomsonreuters.com;))